Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Craniopharyngioma

cetylpyridinium chloride anhydrous has been researched along with Craniopharyngioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biermasz, NR; Dekkers, OM; Pereira, AM; Rabe, KF; Romijn, JA; Smit, JW; van der Klaauw, AA; van Kralingen, KW1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Craniopharyngioma

ArticleYear
Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls.
    Clinical endocrinology, 2008, Volume: 69, Issue:5

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Case-Control Studies; Circadian Rhythm; Craniopharyngioma; Disorders of Excessive Somnolence; Female; Health; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Research Design; Sleep; Surveys and Questionnaires

2008